Navigation Links
Lung Cancer Alliance-Massachusetts Issues Inaugural State-Specific Report Card on Lung Cancer
Date:11/28/2007

vival rate.

-- Number of Late Stage Diagnosis - GRADE: F Over 70 percent of lung cancer patients are diagnosed in the late stages of the disease when it is not curable. We must shift to earlier detection, diagnosis and treatment if we hope to improve overall survival.

-- Newly-Addicted Youth Smokers - GRADE: F 7,400 new Commonwealth "daily" smokers under age 18 become addicted each year.

-- State-Supported Research - GRADE: F Massachusetts has failed to adequately fund research in prevention, early disease management and treatment for lung cancer.

-- State Cancer Plan Commitment - GRADE: D While the plan recommends smoking cessation programs, it fails to recommend research for lung cancer early detection and treatment.

"Now is the time to take action," said Joanne O'Connor, LCA-MA Co-chair. "Lung cancer has been ignored for far too long. LCA-MA will work with hospitals, public health organizations, and legislators throughout the state to ensure Massachusetts becomes a leader in the fight against the number one cancer killer."

For more information on the services provided by Lung Cancer Alliance or to view the complete LCA-MA Report Card on Lung Cancer, visit http://www.lungcanceralliance.org.

Lung Cancer Alliance is the only national non-profit organization dedicated exclusively to patient support and advocacy for those living with or at risk for the disease. Lung Cancer Alliance is committed to reversing decades of stigma and neglect by empowering those with or at risk for lung cancer, elevating awareness, and changing health policy.


'/>"/>
SOURCE Lung Cancer Alliance
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2008)...y 21 /PRNewswire-FirstCall/ -- Aflac Incorporated,...presentation at the Sanford,C. Bernstein & Co., LL...nce,2008., President and Chief Financial Officer ...ted, and he is scheduled to make a presentation on...orated presentation, Mr.,Cloninger will discuss th...
(Date:5/21/2008)...d SILVER SPRING, Md., May 21 /PRNewswire-USNewswir... (ADAA),( http://www.adaa.org ) and The HealthCent... announced that ADAA will join,HealthCentral,s gro...and,health experts dedicated to helping people suf... advice and support they need to cope with the,con...
(Date:5/21/2008)...s 1st quarter profit, enhanced operations and new ...ELES, May 21 /PRNewswire-FirstCall/ -- InstaCare C...butor of at-home testing diagnostics,for the chron...eveloper of,patent-pending technologies for e-heal...s for the first quarter period-ended March 31, 200...
(Date:5/21/2008)... Adverse Events in TORCH Showed Frequency Highest ...ONTO and RESEARCH TRIANGLE PARK, N.C., May 21 /PRN...500/50 (fluticasone propionate and,salmeterol inha...er of,cardiovascular adverse events compared to ot...from the TOwards a Revolution in COPD Health,(TORC...
Breaking Medicine News(10 mins):Health News:Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 2Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 3
...ans – The manner with which an individual responds...an the chronological age, say leading researchers ...rinology. // Healthy aging is all about handling s...estyle. From a review of studies on how stress h...
...ers have explained that the killer disease of H.In...routinely vaccinating the infants Hib vaccine. // ...in their research that the routine vaccination of ...Type b (Hib) significantly reduced invasive Hib di...
...d Health Organisation (WHO), the UN Food and Agric...on of Animal Health (OAH) have decided to set up a...s of zoonoses // , or the diseases that are transm...ystem has become imperative since bird flu, SARS a...
...drome can also cause problems in men, according to...ett Syndrome Study at the Telethon Institute for C...t genetic testing to detect the disease in baby bo...inking in the past had been that Rett syndrome onl...
Other Medicine News:Health News:Studying the psycho neurobiology of aging 2Health News:Studying the psycho neurobiology of aging 3Health News:Researchers claim That Regular Use Of Hib Vaccine In Africa Could Eliminate H. Influenza totally. 2Health News:Researchers claim That Regular Use Of Hib Vaccine In Africa Could Eliminate H. Influenza totally. 3Health News:Rett Syndrome In Men? 2
(Date:5/20/2008)... SEATTLE, May 20 /- Ome...patient enrollment for the Phase 1 study of,OMS201...oduct candidate,for use during urological surgery...roscopic removal of stones with a maximum diameter...r ureter will be enrolled in the,study., "Advanci...
(Date:5/20/2008)... - Study shows significantly improved bronchodil...th combination therapy -, NAPA, Calif., May 20 /P...a demonstrating that patients with Chronic Obstruc... and chronic bronchitis, experienced markedly,impr...ted with a,combination of nebulized formoterol fum...
(Date:5/20/2008)... A Separate Retrospective Analysis of US Employer...Factor Therapies on Absenteeism Among Employees wi...e, SAN DIEGO, May 20 /- Data from a ...ls (ACT 1 and ACT 2) showed that at week 8,more t...rely active,ulcerative colitis (UC) receiving REMI...
(Date:5/20/2008)... Data Presented at the 2008 International Conf...Thoracic Society, TORONTO, May 20 /PRNewswire-Fir...ios Almirall, S.A. today presented results from fo...ty of aclidinium bromide, an,investigational treat...PD).,Data from four preclinical studies further de...
Breaking Medicine Technology:Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study 2Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 2Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 3Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 4Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 5Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 6Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 7New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 2New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 3New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 4New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 5New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 6New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 7New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 8Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 2Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 3Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 4Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 5Kristin Chenoweth to Perform Benefit Concert for 3 Angels Memorial Fund titled Kristin Chenoweth This Ones Personal 3A A Concert to Stop ACD 16531 1Kristin Chenoweth to Perform Benefit Concert for 3 Angels Memorial Fund titled Kristin Chenoweth This Ones Personal 3A A Concert to Stop ACD 16531 2Kristin Chenoweth to Perform Benefit Concert for 3 Angels Memorial Fund titled Kristin Chenoweth This Ones Personal 3A A Concert to Stop ACD 16531 3Amnis Announces Release of Powerful New Image Data Analysis Software 4526 1Amnis Announces Release of Powerful New Image Data Analysis Software 4526 2Monell scientist Mark Friedman awarded Guggenheim Fellowship to study diet and obesity 2850 1Monell scientist Mark Friedman awarded Guggenheim Fellowship to study diet and obesity 2850 2Gel Enables Severed Spinal Cord Fibers to Regrow 16522 1Gel Enables Severed Spinal Cord Fibers to Regrow 16522 2
...7 - CELSION CORPORATION,(AMEX:CLN) today announced...dy, using ThermoDox(R), to treat non-resectable li...Cooperative Research,and Development Agreement (CR...e (NCI) of the National Institutes of Health, unde...Investigator, Head,Tumor Angiogenesis Section, Su...
...NNOVIVE Pharmaceuticals,Inc. (OTCBB: IVPH) today ...f INNO-406, an orally bioavailable dual Bcr-Abl an...,treatment-intolerant chronic myelogenous leukemia...f Clinical Oncology Annual,Meeting. The meeting ta...icago, Illinois., Information related to the prese...
Other Medicine Technology:Celsion Completes Enrollment in Phase I Liver Cancer Study 2Celsion Completes Enrollment in Phase I Liver Cancer Study 3Innovive Pharmaceuticals to Present Interim Data from Phase I Study,of INNO-406 at the American Society of Clinical Oncology Annual,Meeting 2
Unique product designed for LASIK surgery and other types of refractive surgery. Designed to irrigate the corneal interface and/or stromal bed. Flattened tip provides easy insertion under the flap an
Unique product designed for LASIK surgery and other types of refractive surgery. Designed to irrigate the corneal interface and/or stromal bed. Flattened tip provides easy insertion under the flap an
For injecting viscoelastic to all meridians of the anterior chamber and to coat intraocular lenses. 20G x 7.8in (.90 x 22mm).
For administering anesthetic agents into the posterior sub-Tenon's space 20G x 1in (.90 x 25mm)
Medicine Products: